Current Opinion in Supportive and Palliative Care was launched in 2007. It is one of a successful series of review journals whose unique format is designed to provide a systematic and critical assessment of the literature as presented in the many primary journals. The fields of supportive and palliative care are divided into 12 sections that are reviewed once a year. Each section is assigned a Section Editor, a leading authority in the area, who identifies the most important topics at that time. Here we are pleased to introduce the Journal's Section Editors for this issue.
David C. Currow
Professor David C. Currow is currently the Chief Executive Officer of the Cancer Institute, New South Wales, Australia and Chief Cancer Officer for this state. He has previously had the role of foundation chief executive officer of Cancer Australia, the Australian government's national cancer control agency. He continues to hold the appointment of Professor of Palliative and Supportive Services at Flinders University, Adelaide, Australia.
David initially trained as a physician in internal medicine with sub-speciality training in palliative medicine. At the same time, he completed a Master of Public Health exploring changes in the reported incidence of cancer unknown primary in New South Wales over a 25 year time period. Former roles include foundation director of the Nepean Cancer Care Centre, Sydney, Australia and area director of Palliative Services Wentworth Area Health Service, Sydney, Australia. Since 2000 he has had the Chair of Palliative and Supportive Services at Flinders University where there are more than 200 distance students studying at a post-graduate level around the world from a variety of discipline backgrounds. He has published widely in palliative care journals and the general medical literature. Among other projects, he is Co-Chief Investigator on an anthology of evidence for palliative care practice and service delivery – www.caresearch.com.au. Other research interests include the symptomatic management of dyspnoea, improving population based planning for people with life limiting illnesses and improving the evidence base around which clinical decisions are made in palliative care.
David holds grants from the National Health and Medical Research Council, the National Institutes of Health (USA) and the Cancer Councils in Australia. He was on the Board of the International Association of Hospice and Palliative Care and been on the American Society of Clinical Oncology (ASCO) taskforce on palliative care education. He is a former president of the Clinical Oncological Society of Australia and a former president of Palliative Care Australia, the peak body for palliative care in the country. He is a senior Associate Editor of the Journal of Palliative Medicine.
Miriam J. Johnson
Miriam J. Johnson MD; FRCP; MRCP; MBChB(hons) is Professor of Palliative Medicine at the Hull York Medical School, United Kingdon, and is co-director of the Supportive care, Early Diagnosis, Advanced disease (SEDA) research group at the University of Hull, United Kingdom. Her research interests include the palliation of refractory breathlessness, palliative care for patients with advanced heart disease and venous thromboembolism in advanced disease. SEDA uses a variety of study designs and methodologies (clinical trials, qualitative studies, observational studies, secondary data analysis and evidence synthesis). Miriam holds grants from a variety of funders (NIHR, BHF, Marie Curie/CRUK, Dunhill Medical Trust) and has published widely in her field.
She is a member of the NCRI Supportive and Palliative Care Clinical Studies Group, and Deputy Director of the Academic Clinical Training Programme (East Yorkshire). In conjunction with the local cardiologists, she has developed one of the first joint services for heart patients in the UK at St. Catherine's Hospice in Scarborough, United Kingdom, and has edited two of the first books on integrative palliative care for people with heart failure.
Fred Saad MD FRCS, is Professor and Chief of Urology and Director of G-U Oncology at the University of Montreal Hospital Centers (CHUM), Canada. He holds the U of M Endowed Chair in Prostate Cancer Research and is Director of the molecular oncology research lab in Prostate Cancer. He is also Director of clinical cancer research at the CHUM research center (CRCHUM), Canada. Dr Saad is Lead Investigator of the Canadian Prostate Cancer Biomarker Network funded by the Terry Fox Institutes and is a principal investigator with the Movember bio-marker initiatives in prostate cancer. Between 2007–2013 he served as Chair of the National Cancer Institute of Canada G-U Group and the Canadian Urologic Oncology Group. He has published over 300 articles in several prestigious journals such as The New England Journal of Medicine, Lancet, JCO and JNCI. He sits on 7 editorial boards and is a reviewer for over 30 scientific journals. He is an author on over 800 scientific abstracts, 5 books and over 30 book chapters. Dr Saad's research interests include molecular prognostic markers, mechanisms of progression and new therapeutics in prostate cancer. He has over 40 clinical and basic research projects ongoing. To date he has received over 20 million dollars in research grants.
Dr Ellen Warner is a staff medical oncologist at Sunnybrook Health Sciences Centre, Toronto, Canada and a Professor of Medicine at the University of Toronto, Canada. Since 1995 her practice and research have been devoted entirely to breast cancer. She led one of the first teams of researchers to demonstrate the much higher sensitivity of MRI compared to other imaging modalities for the surveillance of women at high risk for hereditary breast cancer.
Dr Warner is the founder and director of PYNK: Breast Cancer Program for Young Women, a clinical, research and educational program (the only one of its kind in Canada and one of the first of its kind in the world) devoted entirely to the population of women diagnosed with breast cancer at age 40 or younger.
Dr Shani Paluch-Shimon is a medical oncologist at Sheba Medical Centre, Tel Hashomer, Israel. Her clinical work and research is devoted to breast cancer with a focus on neo-adjuvant therapies, clinical epidemiology, BRCA1/2 associated breast cancer and breast cancer in young women.
Dr Paluch-Shimon established the Breast Cancer Service for Young Women, with the vision of catering to all the unique medical and psycho-social needs of young women with breast cancer while for each clinical platform providing a parallel research platform.